Jason M. Warram
Papers
1
Total Citations
15
H-Index
1
About
Dr. Jason M. Warram is a leading translational researcher in surgical oncology and molecular imaging, with a primary focus on improving outcomes for patients with head and neck cancers. His key research areas center on fluorescence-guided surgery, particularly the use of targeted optical contrast agents to enhance tumor visualization during minimally invasive procedures. Dr. Warram’s major contribution is pioneering the clinical application of panitumumab-IRDye800CW, a near-infrared dye that binds to EGFR-overexpressing tumors. His landmark work, an interim Phase II study published in 2024, demonstrated the feasibility of using this agent during transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma. This study, which has already garnered 15 citations, addresses a critical clinical challenge: the lack of tactile feedback in robotic surgery. By enabling real-time, high-contrast visualization of malignant tissue, Dr. Warram’s research directly enhances surgical precision, potentially reducing positive margins and improving functional outcomes. His work bridges the gap between preclinical optical imaging and practical intraoperative use, marking a significant step toward standardizing fluorescence-guided TORS and advancing the field of image-guided oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1